Clinical Trial Update: Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions [Phase 1]

View source ↗

Summary

A completed Phase 1 pharmacokinetic study evaluating pirfenidone modified-release tablets in healthy volunteers under fasting and fed conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Overseas Pharmaceuticals, Ltd. | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED